International Stem Cell (OTCQB: ISCO) (aka ISCO)

The world\'s first homozygous parthenogenetic stem cell lines that can provide therapeutic cells with the potential to be transplanted into hundreds o...

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of International Stem Cell (OTCQB: ISCO) (aka ISCO) plus 5056 other startups.

Start Free 7 Day Trial Now

Learn More About International Stem Cell (OTCQB: ISCO) (aka ISCO)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More

Our Clients